Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Wilson disease


Other Names for this Disease

  • Hepatolenticular degeneration
  • WD
  • WND
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment

Management Guidelines

  • GeneReviews provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions. Click on the link to view the article on this topic.

Clinical Trials & Research for this Disease

  • ClinicalTrials.gov lists trials that are studying or have studied Wilson disease. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.

Medical Products

The medication(s) listed in the table(s) below have been approved by the Food and Drug Administration (FDA) for treatment of this condition. The FDA Office of Orphan Products Development designates "orphan products" for those that treat rare diseases affecting fewer than 200,000 Americans. The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products. To search for all FDA approved drugs, visit Drugs@FDA. You can find orphan products used to treat other conditions by searching the Orphan Drug Product Designation database.


Generic Name Zinc acetate
Trade Name
(Manufacturer Name)
Galzin
(Lemmon Company)
Indication
The FDA has approved this product to be used in this manner.
For maintenance treatment of patients with Wilson's disease who have been initially treated with a chelating agent.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Trientine HCl
Trade Name
(Manufacturer Name)
Syprine
(Merck Sharp & Dohme Research)
Indication
The FDA has approved this product to be used in this manner.
Treatment of patients with Wilson's disease who are intolerant, or inadequately responsive to penicillamine.
More Information about this product Drug Information Portal

Other Names for this Disease
  • Hepatolenticular degeneration
  • WD
  • WND
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.